Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples

INTRODUCTION: Subjective cognitive decline (SCD) in cognitively unimpaired older individuals has been recognized as an early clinical at-risk state for Alzheimer’s disease (AD) dementia and as a target population for future dementia prevention trials. Currently, however, SCD is heterogeneously defin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolfsgruber, Steffen, Molinuevo, José Luis, Wagner, Michael, Teunissen, Charlotte E., Rami, Lorena, Coll-Padrós, Nina, Bouwman, Femke H., Slot, Rosalinde E. R., Wesselman, Linda M. P., Peters, Oliver, Luther, Katja, Buerger, Katharina, Priller, Josef, Laske, Christoph, Teipel, Stefan, Spottke, Annika, Heneka, Michael T., Düzel, Emrah, Drzezga, Alexander, Wiltfang, Jens, Sikkes, Sietske A. M., van der Flier, Wiesje M., Jessen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337830/
https://www.ncbi.nlm.nih.gov/pubmed/30654834
http://dx.doi.org/10.1186/s13195-018-0463-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337830/
https://www.ncbi.nlm.nih.gov/pubmed/30654834
http://dx.doi.org/10.1186/s13195-018-0463-y

Ejemplares similares